GoodRx Holdings (GDRX) Other Non-Current Liabilities (2019 - 2026)

GoodRx Holdings has disclosed Other Non-Current Liabilities across 8 years of filings, most recently posting $8.7 million for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $8.7 million, up 25.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.7 million (up 25.79% YoY), and the FY2025 annual result was $8.7 million, up 29.4% from the prior year.
• Other Non-Current Liabilities came in at $8.7 million for Q1 2026 at GoodRx Holdings, down from $8.7 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $9.6 million in Q2 2023 to a low of $4.7 million in Q1 2022.
• The 5-year median for Other Non-Current Liabilities is $7.8 million (2023), against an average of $7.7 million.
• Across the five-year window, Other Non-Current Liabilities dropped 25.09% in 2022 and jumped 70.04% in 2023, its largest moves.
• GoodRx Holdings' Other Non-Current Liabilities stood at $7.6 million in 2022, then climbed by 8.2% to $8.2 million in 2023, then fell by 17.39% to $6.8 million in 2024, then rose by 29.4% to $8.7 million in 2025, then retreated by 0.56% to $8.7 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $8.7 million (Q1 2026), $8.7 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.